Spanish venture capital house Inveready has led a €3.5m funding round for Barcelona-based drug developer Leukos Biotech.
Inveready drew capital from its Inveready Innvierte Biotech II vehicle. As part of the deal, two representatives from Inveready will take seats on the company's management board. The company intends...
New recruit will provide financial due diligence to PE houses and other investors
Backers include Italian VC firms P101 and 360 Capital Partners, and angel investor Mike Brennen
New vehicle has received the backing of two LPs including Legal & General
Momentous changes in the UK's healthcare provision space and the potential for growth in related subsectors present opportunities for private equity